Inactive Instrument

News MolMed S.p.A. CBOE EUROPE EQUITIES

Equities

0IE3

IT0001080248

End-of-day quote CBOE EUROPE EQUITIES Other stock markets
- ^EUR	-

2023	Genenta Science S.p.A. and AGC Biologics S.p.A. Enter into A Development and Manufacturing Services Agreement	CI
2022	AGC Biologics and W.L. Gore & Associates Collaborate on New Protein A-Based Purification Technology and Contract Manufacturing Services for Antibody Therapies	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genenta Science S.p.A. and AGC Biologics S.p.A. Enter into A Development and Manufacturing Services Agreement	02/23/02	CI
AGC Biologics and W.L. Gore & Associates Collaborate on New Protein A-Based Purification Technology and Contract Manufacturing Services for Antibody Therapies	12/22/12	CI
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies	16/22/16	CI
AGC Biologics Partners with BioNTech SE to Further Supply Plasmid DNA Starting Material for the Pfizer-BioNTech COVID-19 vaccine, at AGC’s Heidelberg, Germany facility	07/21/07	CI
MolMed Announces Transition of Luca Alberici from the Role of Chief Business Officer	12/20/12	CI
MolMed S p A : CS_ integrativo del Comunicato dimissioni consiglieri	06/20/06	PU
MolMed S.p.A.(BIT:MLM) dropped from S&P Global BMI Index	03/20/03	CI
AGC Inc. completed the acquisition of 93.2% in MolMed S.p.A. from Finanziaria d'investimento Fininvest S.p.A. and others for approximately €220 million.	24/20/24	CI
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration	09/20/09	CI
AGC : Italy to use vetting powers in Molmed acquisition by Japan's AGC	07/20/07	RE
University of Tartu: Novel DNA analysis will help to identify food origin and counterfeit food in the future	08/20/08	AQ
Karolinska Institutet: Overlooked protein could play important part in pneumonia and COVID-19, researchers say	08/20/08	AQ
University of Bristol: UK genome analysis has important implications for COVID-19 clinical trials	02/20/02	AQ
AGC Inc. entered into an agreement to acquire MolMed S.p.A. from Finanziaria d'investimento Fininvest S.p.A. and others for approximately €240 million.	17/20/17	CI
MolMed S p A : KU awards 38 PhD, 16 M. Phil, two Master of Surgery degrees	12/20/12	AQ
MolMed S p A : Karachi University awards 38 MPhil, 16 PhD degrees - Press Release issued by University of Karachi	12/20/12	AQ
Molmed S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2019	09/20/09	CI
MolMed S p A : RhoVac announces appointment of Professor Anne J. Ridley to its Scientific Advisory Board	06/20/06	AQ
MolMed S p A : UCT Shines At L'oréal-Unesco Sub-Saharan Africa	06/19/06	AQ
MolMed S p A : KU awards 34 PhD, 36 MPhil degrees	04/19/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MolMed S.p.A. CBOE EUROPE EQUITIES

Equities

0IE3

IT0001080248

Summary

Filters